Log In
BCIQ
Print this Print this
 

ATC-1906

  Manage Alerts
Collapse Summary General Information
Company Altos Therapeutics LLC
DescriptionOral dopamine D2 and D3 receptor antagonist
Molecular Target Dopamine D2 receptor ; Dopamine D3 receptor (DRD3)
Mechanism of ActionDopamine D2 receptor antagonist; Dopamine D3 receptor antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/03/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today